A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199

Clinical trial NCT01969682 · WITHDRAWN

Trial details

NCT number: NCT01969682
Sponsor: AbbVie
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2014-04-01
Primary completion: 2014-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.